Jigar Raythatha invests as a partner at Third Rock Ventures and serves on the boards of Flare Therapeutics and Synnovation Therapeutics and as chairman of TRIANA Biomedicines. Previously led Constellation Pharmaceuticals as CEO and held roles at Jounce Therapeutics, Red Abbey, Biogen and A.T. Kearney.
Jigar Raythatha invests as a partner at Third Rock Ventures and serves on the boards of Flare Therapeutics and Synnovation Therapeutics and as chairman of TRIANA Biomedicines. Previously led Constellation Pharmaceuticals as CEO and held roles at Jounce Therapeutics, Red Abbey, Biogen and A.T. Kearney.
Career
Jigar Raythatha holds a BA, Biochemistry and Economics from Rutgers University and an MBA from Columbia University.
TRPartner at Third Rock Ventures until Present
FTBoard Member at Flare Therapeutics until Present
STBoard Member at Synnovation Therapeutics until Present
TBChairman at TRIANA Biomedicines until Present
CPChief Executive Officer at Constellation Pharmaceuticals from 2017 to 2021